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Introduction : les patients obèses morbides présentent un risque majeur de 
développer des calculs biliaires en raison d'une sécrétion accrue de cholestérol dans 
la bile. Ce risque, davantage élevé dans la phase de perte pondérale rapide 
consécutive à la chirurgie bariatrique ou lors de régimes amaigrissants, est souvent 
la cause de nombreux symptômes, voire de complications biliaires. Aussi 
l'association d'une cholécystectomie à la chirurgie bariatrique, notamment le by-
pass gastrique laparoscopique a-t-elle été proposée afin d'éviter ces complications 
parfois redoutables dans cette population fragile. Ce concept a cependant fait l'objet 
de démentis dans de récentes études où ce risque apparaîtrait moins élevé, et la 
cholécystectomie durant le by-pass gastrique laparoscopique pourrait être grevée de 
difficultés et présenter des risques opératoires non négligeables pour le patient. 
Patients et méthodes : notre série comporte 772 patients opérés entre 2000 et 2007 
par by-pass gastrique laparoscopique, avec montage d'une anse en Y selon Roux. 
Ces patients obèses morbides avaient été sélectionnés sur la base d'une anamnèse 
concluante, d'un examen anthropométrique, d'un bilan sanguin et d'un ultrason 
abdominal. Une analyse rétrospective des résultats d'ultrason abdominal pré-
opératoire et des rapports histopathologiques des vésicules biliaires en post-
opératoire a été réalisée chez les patients opérés avant 2004. 
Résultats: 58 patients (7,5 %) avaient déjà eu une cholécystectomie. L'US 
abdominal a révélé des calculs ou de la boue biliaire chez 81 patients ( 11,3 % ), un 
polype chez un patient et une vésicule biliaire normale chez les patients restants. La 
cholécystectomie a été réalisée concomitamment au by-pass gastrique chez 665 
patients (91,7 %) et des calculs biliaires retrouvés à l'examen per-opératoire des 
vésicules biliaires chez 25 patients (3 ,9 % ), rapportant alors la prévalence de la 
cholélithiase à 21,2 % dans cette population. L'âge des patients porteurs de calculs 
biliaires était significativement plus élevé que celui des patients sans calculs biliares 
(43,5 contre 38,7 ans, P < 0,0001). A l'examen histopathologique, des anomalies 
ont été décrites dans 81,8 % des vésicules biliaires, consistant pour la plupart en 
cholécystite chronique et cholestérolose. 
Aucune complication post-opératoire n'a été associée à la cholécystectomie et le 
prolongement du temps opératoire était en moyenne de 19 minutes (4 - 45 minutes) 
sans aucun impact sur le séjour hospitalier. La cholécystectomie n'a pas été réalisée 
chez 59 patients (8,3 %) en raison de conditions opératoires défavorables, 
notamment une exposition insuffisante. Un traitement d'acide ursodésoxycholique 
a été prescrit sur une période de 6 mois et aucun de ces patients n'a manifesté de 
symptômes biliaires. 
Conclusion : la cholécystectomie peut être réalisée à titre prophylactique et en toute 
sécurité au cours du by-pass gastrique laparoscopique. Cet acte opératoire 
supplémentaire sans conséquence sur le séjour hospitalier, constitue selon la 
présente étude une forme de prophylaxie recommandable dans la prévention de la 
formation des calculs biliaires dans la phase de perte pondérale post-opératoire. Sa 
supériorité ou non par rapport à la prophylaxie médicamenteuse à l'acide 
ursodésoxycholique n'a pas encore été établie. Des études prospectives randomisées 
seraient nécessaires afin de confirmer l'avantage de l'une ou l'autre de ces deux 
alternatives. 
Mots-clés: obésité morbide, by-pass gastrique laparoscopique, cholécystectomie, 
cholélithiase. 
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Abstract 
Background Morbidly obese patients are at high risk to 
develop gallstones, and rapid weight loss at1er bariatric 
surgery further enhances this risk. The concept of prophy-
lactic cho lecystectomy dlll'ing gastric bypass bas been 
challenged recently because the risk may be lower than 
reported earlier and because cholecystectomy during lapa-
roscopie gastric bypass may be more difficult and risky. 
Methods A review of prospectively col!ected data on 772 
patients who undetwent laparoscopie primary gastric bypass 
between January 2000 and August 2007 was performed. The 
charts of patients operated be fore 2004 were retrospectively 
reviewed regarding preoperative echogrnphy and. histo-
pathological findings. 
Results Fifty-eight (7.5%) patients had had previollS chole-
cystectomy. In the remaining. patients, echography showed 
gallstones or sludge in 81 ( 11.3%). Cholecystectomy was 
performed at the time of gastric bypass in 665 patients 
(91.7%) .. Gallstones were found intraoperatively in 25 
patients (3.9°/ci), for a total prevalence of gallstones of 
21.2%. The age of patients with gallstones was higher than 
that of gallstone-free patients (43.5 vs 38. 7 years, p <0.0001 ). 
Of the removed specimens, 81.8% showed abnormal 
histologie findings, mainly chronic cholecystitis and cho-
lesterolosis. Cholecystectomy was associated with no 
procedure-related complication, prolonged duration of 
surgery by a me an of 19 min ( 4-45), and had no effect on 
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the duration of hospital stay. Cholecystectomy was deemed 
too risky in 59 patients (8.3%) who were prescribed a 
6-month course of ursodeoxycolic acid. 
Conclusion Concomitant cholecystectomy can be perfonned 
safely in most patients during laparoscopie gastric bypass and 
does not pro long hospital stay. As such, it is an acceptable form 
of prophylaxis against stones forming during rapid weight 
loss. Whether itis superiorto chemical prophylaxis remains to 
be demonstrated in a large prospective randomized study. 
Keywords Morbid obesity · Gastrie bypass · 
Cholecystectomy · Gallstones 
Introduction 
The prevalence of obesity is increasing almost exponentially 
worldwide, resulting in an enormous rise in the number of 
bariatric procedures performed each year. In the severely 
obese patients, cholesterol secretion by the !iver is increased. 
This results in an increased cholesterol concentration in the 
bile without a proportional increase in phospholipids and bile 
salts [ 1, 2], which makes it difficult to main tain the cho-
lesterol in solution. Obese patients also have a larger 
gallbladder with a reduced contractility [3]. These different 
mechanisms are responsible for an increased prevalence of 
gallstones in obese patients. Numerous studies have shown 
that the prevalence of ga!lbladder pathology, and especially 
ga!lstones, is three to five times higher in obese patients 
compared with the general population [ 1, 2, 4-11 ]. Weight 
loss associated with low-calorie diet, and especially rapid 
weight loss that follows bariatric surgery, further enhances 
the lithogenicity of the bile by increasing cholesterol 
secretion even more. Some bariatric procedures like Roux-
en-Y gastric bypass (RYGBP) reduce the post-prandial level 
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of cholecystokinin, resulting in poor gallbladder emptying, 
and thereby altering the entero-hepatic circulation of biliary 
salts [2, 8, 12, 13]. These mechanisms also contribute to a 
higher risk of developing gallstones after bariatric surge1y. 
Because of the high prevalence of gallstone disease in 
morbidly obese patients and the high risk to develop 
gallstones during rapid weight loss after bariatric surgery, 
we decided to perform routine prophylactic cholecystec-
tomy in our morbidly obese patients unclergoing RYGBP, 
provided the intraoperative finclings clid not preclude a 
safe dissection. In this paper, we report the results of this 
policy with respect to safety, pre- and intraoperative 
findings, and histological findings, and cliscuss whether 
routine prophylactic cholecystectomy is justified during 
laparoscopie RYGBP. 
Patients and Methods 
Patients with.a body mass index (BMI) in excess of 40 kg/m 2, 
or >35 kg/1112 with at least one severe comorbidity, were 
offered laparoscopie Roux-en-Y gastric bypass after failure 
of conservative treat111ent and complete evaluation by a 
multidisciplinary team. Contraindications were according to 
the consensus develop111ent conference panel of the 
National Institute ofHealth and to the consensus on obesity 
treatment in Switzerland [ 14, 15]. 
Preoperative evaluation included, among others, upper 
gastrointestinal endoscopy and abdominal echography in ail 
patieùts. The aim of the latter was to assess the size of the 
liver and to detect gallbladder stones. Gastroscopy was 
used to exclude gastro-duodenal lesions before Roux-en-Y 
gastric bypass and to detect fle/icobacter pylori infection so 
as to eradicate it before smge1y. 
Our general policy was to offer concomitant cholecystec-
tomy at the fane oflaparoscopic RYGBP to ail patients. The 
presence of gallstones, symptomatic or not, was the reason in 
those in whom these were detectecl preoperatively by 
echography. In the re111aining patients, the high incidence of 
gallstone formation after RYGBP, as reported in the 
literature, and the potential for long-term stone-related 
complications, was given as the reason for prophylactic 
cholecystecto111y. No patient refused cholecystectomy. The 
patients were explained, however, that cholecystectomy 
would only be perfor111ed if the surgeon considered it safe 
at the end of the RYGBP in regards to local and general 
conditions of the patient. 
Since the introduction of laparoscopie bariatric surgery 
in our department in Decernber 1995, a prospective 
computerized bariatric database has been created, including 
preoperative patient's demographic and anthropometric 
data, comorbidities, operative and follow-up data. All 
patients undergoing laparoscopie RYGBP between January 
%) Springer 
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2000 and August 2007 were included in this series. The 
charts ·of those operated between 2000 and 2004 were 
reviewed in details for data regarcling the results of 
preoperative echography and histological examination of 
the gallbladder. 
Ali patients were given prophylactic antibiotics (amoxicil-
line-clavulanate 2.2 g, or ciprofloxacine 200 mg and 
metroniclazole 500 mg for those allergie to penicillin) 
intravenously at the induction of anesthesia. Prophylaxis 
against thromboembolism was started either the evening 
before surgery or at the induction of anesthesia using low-
111olecular-weight heparin at a dose that was adapted to the 
patient's body weight and pursued until the end of the second 
postoperative week. The surgical technique used for RYGBP 
included six trocars and has been described in details 
elsewhere [ 16]. After co111pletion of gastric bypass and in the 
absence of any major intraoperative complication, the right 
upper quadrant was assessed for the feasibility of cholecys-
tectomy. Ifexposure was deemed sufficient, and in the absence 
of severe adhesions surrounding the gallbladder, cholecystec-
tomy was performecl using the same trocars and instrnments 
used for the primary procedure. No additional trocar was 
placed. Dissection of the gallbladder was performed using the 
Ultracision 10 111111 (Ethicon Endo-surgery, 8957 Spreitenbah, 
Switzerland). No intraoperative cholangiography was per-
fonned. The gallbladder was delivered from the abdominal 
cavity through the 15-111m trocar incision, usually after 
transparietal puncture and aspiration of the bile. At the end of 
the procedure, a Jackson-Pratt drain was placed in the vicinity 
of the gastrojejunostomy, and a Penrose drain was left in the 
15-mm trocar incision. 
Results 
A total of772 patients underwent laparoscopie RYGBP as a 
pri111ary bariatric procedure in our depart111ent between 
J anuary 2000 and August 2007. There were 186 men and 
586 women with a mean age of39.8 years (extremes 18-66). 
The mean preoperative weight was 126.2 kg (86-227), and 
the mean BMI was 45.6 kg/1112 (34-73.4). Fifty-eight (7 .5%) 
of these patients had undergone prior cholecystectomy and 
were excluded from further analysis. In the remaining 714 
patients, preoperative echography disclosed gallbladder 
stones in 81 patients (10.5%), and a small polyp of the 
gallbladder in one patient. 
Cholecystectomy was performed at the ti111e oflaparoscopic 
RYGBP in 655 (91.7%) ofthese 714 patients. The indication 
was asymptomatic gallstones in 79 patients and routine 
prophylaxis of postoperative cholelithiasis in the others. 
Among the latter patients, with nonnal preoperative findings 
on transabdominal echography, 25 (3.9% false negative 
findings) were found to have gallstones intraoperatively. The 
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total prevalence of gallstones in the en tire series \Vas therefore 
21.2%. Cholecystectomy was not perfo1111ed in two patients 
with known asymptomatic cholelithiasis because exposure in 
the right upper quadrant was considered insufticient. In the 
remaining 54 patients, poor visibility was the reason for not 
performing cholecystectomy in 47 patients and liver cirrhosis 
discovered at surgery in four. Three patients, who were 
Jehovah witnesses, were not submitted to cholecystectomy to 
avoid any associated risk ofhemorrhage. Patients who did not 
undergo cholecystectomy at the time of surgery were 
prescribed ursodesoxycholic acid orally for 6 months. 
The mean age of patients with gallstones at RYGBP or a 
hist01y of prior cholecystectorny was significantly greater 
than that of patients without gallstones ( 43 .5 versus 
38.7 years, p<0,0001, t test). There was no difference 
between the two groups regarding preoperative weight, 
BMI, or waist circumference. Patients who underwent 
concomitant cholecystectomy at the time of laparoscopie 
RYGBP were younger (38.9 versus 44.6 years, p<0,0001, 
t test), had a slightly lower BMI (45.4 versus 46.7 kg/m 2, 
p=0.04, t test), and a lower weight (125.4 versus 130.9 kg, 
p=0.01, t test) than those in whom cholecystectomy was 
not perfonned. The mean o.verall duration of surgery was 
significantly shorter in patients with concurrent cholecys-
tectomy than in the remaining on es (142. 6 versus 
158.6 min, p=0.0001, t test). This mostly reflects the 
greater overall technical difficulties encountered during the 
performance of gastric bypass in patients in whom 
cholecystectomy was deerned too risky. In a consecutive 
group of 1 OO patients, the additional time required for 
cholecystectomy was monitored and found ta be 19 min 
(5-45 min). Cholecystectomy was associated with no specific 
morbidity, except for one accidentai puncture of the junction 
of the cystic duct and the common bile duct by a clip in a 
patient with gallstones. The latter was irnmediately closed 
with a single stitch without any short- or long-term 
consequence. There was no difference in the duration of 
hospital stay between patients with and without concomitant 
cholecystectomy (median 4 days in bath groups). 
Between 2000 and 2004, 351 patients underwent 
prophylactic cholecystectomy during laparoscopie RYGBP, 
257 women and 94 men, with a mean age of 41. l years 
(19-60 years). Theîr mean BMI was 45. 7, similar to that of 
the whole series. Twenty-eight patients had had prior 
cholecystectomy, and cholecystectomy was deemed risky 
and therefore not performed during RYGBP in 38 patients. 
Cholecystectomy was therefore performed during RYGBP 
in 285 patients. In those who still had their gallbladder in 
place, preoperative echography showed stones in 54 
patients (17%). The gallbladder coule! not be visualized on 
preoperative ultrasound examination in five patients ( 1.6%) 
because of technical difficulties. Table 1 shows the findings 
of the pathological examination of the gallbladder in tbis 
Table 1 Results of histopathological examination of the gallbladder 
Type of lesion Number (%) Sex ratio 
Chronic cholecystitis (CC) 180 (63.8) 133/47 
Cholesterolosis 144(51.0) 116/28 
CC + cholesterolosis 94 (33.3) 73/21 
Unknown gallstones 11 (3.9) 615 
Cholesterol polyp 2 (0.7) 0/2 
Metaplasia 3 (1.0) 2/1 
Dysplasia l (0.3) 0/1 
Adenomyosis 1 (0.3) l/O 
Total abnonnal 230 (81.6) 156173 
group. The latter was totally norrùal in only 52 (18.2%) 
patients. The most common findings were chronic chole-
cystitis in 180 patients (63.8%), followed by cholesterolosis 
in 144 (51%). There was no relationship between histolog-
ical findings and age or BMI. Gallstones (5:4) and 
cholesterolosis (4:3) were more common in women, whereas 
chronic cholecystitis was more prevalent in men (7:6). 
Discussion 
Our results show that ahnost routine cholecystectomy at the 
time of laparoscopie RYGBP is very safe, that echography 
can be misleading, and that the vast majority of gallblad-
ders in morbidly obese patients show histopathological 
abnonnalities. 
According to the literature, the prevalence of gallstones 
in morbidly obese patients varies between 19 and 45% 
(1, 4, 6, 8, 9, 13, 18, 19], and up to 25% of patients have 
undergone cholecystectomy before bariatric surge1y. Our 
results grossly fall within these ranges. Dittrick et al. [ 19] 
compared gallbladder histopathological findings in 478 
morbidly obese patients with a contra! group of 481 liver 
donors. Seventy-two percent had abnormal findings at 
histological examination in the obese group, compared 
with 21% in the liver donors. Liem and Niloff (18] found 
abnormalities in 75% of gallbladders routinely removed in 
141 patients and Aidonopoulos 97% in 64 patients. In 761 
patients undergoing RYGBP reported by Fobi et al. [8], the 
incidence of gallbladder pathology was 86.2%. 
Rapid weight loss after bariatric surgery is associated 
with an even greater risk to develop gallstones than obesity 
per se. Deitel and Petrov (20] reported an 11.5% incidence 
after bariatric surgery, and Kamrath et al. (21] noted 10.3% 
symptomatic gallstones with a very low calorie diet. 
Shiffman et al. [12] reported that 49% of 81 patients 
developed gallstones or sludge within 6-18 months of 
RYGBP, 28% of them requiring cholecystectomy. Schmidt 
et al. [6] found that 40% had developed cholelithiasis 
and/or required cholecystectomy after RYGBP. Amaral and 
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Thompson [lO] repo1ied a 27.6% incidence of complications 
related to gallstones after bariatric surge1y, including com-
mon duct stones and pancreatitis. Some form of prophylaxis 
seems therefore warrnnted. A survey of members of the 
ASBS totaling more than 8,000 patients showed that 40% still 
had their gallbladder after the bariatric procedure and were, 
therefore, at risk to develop gallstones [1). 
Another way to prevent gallstones after bariatric surge1y 
is chemoprophylaxis with ursocleoxycholic acid (UDA) 
during rapid weight loss. In a randomized study, Sugerman 
et al. [22) showed that a 6-month course of this drug was 
superior to placebo (2 vs 32%). UDA is also effective with 
low-calorie diet [23). Corn pl iance may be Iirnited, but the 
drug has been shown to be cost-effective [24, 25). 
Recently, routine prophylactic cholecystectomy during 
RYGBP has been challenged by several authors, arguing 
that the risks rnight outweigh the benefit, but also because 
newer sh1dies reported a much lower incidence of gall-
stones, especially symptomatic on es. Hamad et al. [ 17) 
found that in a group of 94 patients, cholecystectomy 
during laparoscopie RYGBP prolonged smgery by more 
than an hour and hospital stay by more than 1 day. Our 
resu!ts are not in accordance. with the above regarding 
duration of surgery and hospital stay. Another group 
recently found sirnultaneous cho!ecystectomy to prolong 
surge1y by a mean of 29 min, with no effect on hospital 
stay [26), and Villegas et al. [27] reported the additional 
operative tiine devoted to cholecystectorny to be 20 min, 
very similar to ours. In the sarne series, 45% of the patients 
without cholecystectomy were found to have developed 
gallstones or sludge within 6 months of RYGBP .. but only 
one fomih of these patients (7 .3% of the total) developed 
stone-relatecl symptoms including cholangitis and septic 
shock. Patients compliant with drug prevention developed 
fewer stones. In the sh1dy of Ham ad et al. [ J 7), only eight 
patients (2.3%) who did not undergo cholecystectomy 
developed symptomatic stones during a 12-month follow-
up. Another group recently reported on a large group of 
RYGBP patients without prophylaxis, of whom 8.1 % 
developed gallstone-related symptoms and eventually re-
quired cholecystectomy. Both authors concluded that the 
incidence of symptomatic gallstones was low and that 
routine cholecystectomy was probably not mandatory [28). 
Clearly, rapid weight loss after RYGBP is associated 
with a markedly increased prevalence of gallstones and 
gallbladder histopathological abnormalities, which may 
predispose to gallstones. The aclvantage of routine prophy-
lactic cholecystectomy in RYGBP patients is that it reduces 
to zero the risk to develop gallblaclder stones and their 
possible complications. This must be balanced with the 
risks associated with cholecystectomy. Laparoscopie cho-
lecystectomy is safe in obese patients [29-31]. In patients 
~ Springer 
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undergoing laparoscopie RYGBP, placement of the trocars 
is not ideal for cholecystectomy and may make it more 
clifficult. In our series, however, cholecystectomy, when 
attempted, could always be completed without complication. 
Cholecystectomy has been associated with a variety of 
postoperative gastrointestinal symptoms, with major 
changes reported in up to 12% of patients [32-34]. Results 
from different studies, however, are inconsistent. Severe 
diarrhea is extremely rare after cholecystectomy. The fear to 
cause post-cholecystectomy symptoms should not be a 
reason for avoiding cholecystectomy during RYGBP. 
In conclusion, the incidence of gallbladder pathology is 
high. Without any form of prophylaxis, gallstones develop 
in a significant number of patients after RYGBP, and there 
seems to be a consensus on the need for prevention. We can 
recommend prophylactic cholecystectomy as a safe method 
in the majority of patients, provided exposure of the 
gallbladder area is sufficient. In the remaining patients, a 
6-month course of ursodeoxycholic acid at 600 mg daily 
seems adequate. Only a large prospective randomized trial 
comparing cholecystectomy at the time of RYGBP with a 
6-month pharmacological prevention will answer the 
question as to which method is superior for gallstone 
prophylaxis after RYGBP. 
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